- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Status of adjuvant endocrine therapy for breast cancer ; volume:16 ; number:2 ; day:1 ; month:4 ; year:2014 ; pages:1-17 ; date:4.2014
Breast cancer research ; 16, Heft 2 (1.4.2014), 1-17, 4.2014
- Urheber
-
Schiavon, Gaia
- Beteiligte Personen und Organisationen
-
Smith, Ian E.
SpringerLink (Online service)
- DOI
-
10.1186/bcr3636
- URN
-
urn:nbn:de:1111-2016032419598
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schiavon, Gaia
- Smith, Ian E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
Complexities in Adjuvant Endocrine Therapy for Breast Cancer in Female-to-Male Transgender Patients
Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform
![Endocrine therapy of breast cancer, [1]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
Adjuvant therapy of primary breast cancer
Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
Complexities in Adjuvant Endocrine Therapy for Breast Cancer in Female-to-Male Transgender Patients
Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
Adjuvant therapy of primary breast cancer
Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
Complexities in Adjuvant Endocrine Therapy for Breast Cancer in Female-to-Male Transgender Patients
Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
Adjuvant therapy of primary breast cancer